Log inTry free

Scribe Therapeutics (SCTX) stock

Market cap $325M

$16.33
+0.74%

Market closed. Prices as of Tuesday's close.

Quality Score
-1
Poor
In its industry
#163of 308
Biotech

New listing, trading since Jul 24, 2026. 52 trading days so far, so 4 of the 14 checks wait for more history.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 14 checks on SCTXSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Holding it back

Moves 21.1% a day with no profit behind it.

Why SCTX scores -1

PoorTrending down, 1 of 14 checks firingWhat the Quality Score means

Poor is below 0. Average starts at 6, Above Average at 11, Excellent at 15, and Exceptional at 20.

  • +1Chart checks 1 of 14 firing right now, one point each
  • −2Volatility moves 21.1% a day with no profit or positive free cash flow over four quarters on fileA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

No effect today: Long-term trend, Run-up, Size, Profit, Growth, Dilution, Cash flow, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on SCTX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 1:29 AM ET, at least 15 minutes behind. How we rank stocks.

What's next

Expected to report Wed Nov 11, after the close

After its last report it closed -0.3%.

Sat Jan 23: IPO lockup endsAt the open. Sellable from Mon Jan 25 · The 180-day lockup ends.

2 more dates ahead for Pro members: the conference and the IPO anniversary

What would turn SCTX's score around: 3 things, for Pro members

Alert me when SCTX's Quality Score turns up

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price with the bid and ask.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on SCTX and every other stock.

  • Why a stock ranks

    Its Quality Score, its rank, and the reasons behind it, on one card.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, download a CSV, and set optional alerts.

  • Congress trades

    Each member's trades. Sort, filter, download a CSV, and set optional alerts.

  • All 14 chart checks

    Trend, volume, tight range, and buying, each lit when it fires, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports. Optional alerts before them.

  • FDA dates, counted down

    Each date in the company's own words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    AI chips, quantum, nuclear, defense, space, and more, each stock ranked by its Quality Score.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push, email, or the bell.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name, with optional alerts.

  • A trade plan, from the chart

    Entry, stop, and two targets on every stock's page. Type your risk and it sizes the trade.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

SCTX has 1 of 14 checks firing

One per group is shown here.

Trend1 of 5 shown
MA FAN21 EMAW.EMAHH/HL52W HI

Averages stacked in order, price near its high.

Volume1 of 3 shown
VOLVDUU/D VOL

Heavy volume on the run, quiet volume at rest.

Tight range1 of 3 shown
ATR SQZSQUEEZENR7

The daily range is tight against its own recent history.

Buying1 of 3 shown
OBV+CLOSE HISPRING

Closes near the high, and buyers step in on dips.

The other 10 checks on SCTX, and all 14 on every stock.Get in free →

Also on the chart

Not scored

Shown for reference. None of these counts toward the Quality Score: in our tests on 20 years of daily prices, none of them improved it.

How SCTX ranks in Biotech

SCTX is #163 of 308 by Quality Score. The top three are shown with their scores, and more by name.

More in Biotech, on the Healthcare page

When does SCTX report earnings, and what happens after?

Expected to report Wed Nov 11, after the close (in 35 days). Not yet confirmed by the company.

ReportedGapReaction5 sessions
Sep 2, 2026After close+0.3%-0.3%-4.6%

The gap is the next open against the close before the report; the reaction is where that session closed. SCTX closed higher after 0 of its last 1. Past behavior, not a forecast.

Report dates and past reactions come from sessions that have already closed, so none of these figures move.

Who is trading SCTX

SCTX insider trades

4 insiders bought $6.3M across 5 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyAH BIO Fund II, L.P.$5M10% ownerat $15.00 on Jul 27, filed Jul 29
All 5 insider filings on SCTX from the last six months, for Pro members.Get in free →

An insider has two business days to file a Form 4, so the trade is already days old when it becomes public. Shown as filed, with no delay.

SCTX's officers and directors

Officers and directors with a Form 4 here in the last 3 months. Open one for their trades at every company.

See insider trades by person

About Scribe Therapeutics

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Alameda, CAscribetx.com

Pro members see every line of every stock's score.

  • Real-⁠time prices, no delay
  • Every line of SCTX's score, with the points and the reason
  • All 14 checks on SCTX and on all 3,283 stocks
  • Every stock ranked, with the chart
  • Every filing, and optional alerts on SCTX
BreakawayJul 29AH BIO Fund II, L.P. bought SCTX$5M at $15.00, filed Jul 29

What a filing on SCTX would have sent. Alerts are optional.

See all 14 checks on SCTXSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Where does the data come from?

Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.

Do I need an account?

Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.

Is this investment advice?

No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.